US Representative

Doug Lamborn 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 9)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3889

Introduced
6/7/23  
No Federal Funding for CCP Spying and Persuasion In Education Settings (SPIES) Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB398

Introduced
1/20/23  
Refer
1/20/23  
Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB407

Introduced
1/20/23  
Refer
1/20/23  
Protect the UNBORN (Undo the Negligent Biden Orders Right Now) Act or the Protect the UNBORN Act This bill prohibits federal implementation of and funding for specified executive orders that address access to reproductive health care services, including services related to pregnancy or the termination of a pregnancy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4076

Introduced
6/13/23  
Refer
6/13/23  
United States-Israel Health Technologies Cooperation Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4151

Introduced
6/15/23  
To amend the Internal Revenue Code of 1986 to require certain contract terms in contracts relating to wind turbines on land not owned by the taxpayer as a requirement in order to claim the credit relating to electricity produced from certain renewable resources.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4152

Introduced
6/15/23  
Refer
6/15/23  
Space Resources Institute Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4175

Introduced
6/15/23  
Refer
6/15/23  
REPO for Ukrainians Act Rebuilding Economic Prosperity and Opportunity for Ukrainians Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4196

Introduced
6/16/23  
Refer
6/16/23  
One Flag for All Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB421

Introduced
1/20/23  
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4235

Introduced
6/21/23  
Refer
6/21/23  
Refer
8/21/23  
Refer
11/9/23  
Wildfire Technology Demonstration, Evaluation, Modernization, and Optimization Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4238

Introduced
6/21/23  
Kate's Law Stop Illegal Reentry Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4278

Introduced
6/22/23  
Refer
6/22/23  
Refer
7/10/23  
Restore VA Accountability Act of 2023 Restore Department of Veterans Affairs Accountability Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB429

Introduced
1/20/23  
No Tax Breaks for Radical Corporate Activism Act This bill disallows a business expense tax deduction for any reimbursement paid by an employer to an employee for travel expenses to obtain an abortion, or for the costs of any gender transition procedure for the employee's minor child.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4297

Introduced
6/22/23  
Refer
6/22/23  
Refer
1/30/24  
Bolts Ditch Act